4.16
アゴニストが最大の反応を引き起こしても、一部の受容体は未使用のままです。これらの空の受容体は予備の受容体と呼ばれます。予備の受容体が存在する場合、アゴニスト薬の最大有効性は受容体の100%を占有する必要なく達成されます。予備の受容体の存在を確認するために、科学者はしばしば最大有効性の50%を引き起こ…
典型的には、アゴニストは、利用可能な全受容体の一部のみを結合することにより、最大の生物学的応答を生じる。空いているものはスペア受容体と呼ばれます。
予備の受容体は、2つのメカニズムから生じる可能性があります。一部の経路では、1つのアゴニスト-受容体複合体が多くの中間タンパク質分子と相互作用して、複数のエフェクター分子を活性化します。そのため、受容体の数は利用可能なエフェクター分子を超え、多くの受容体に余裕が残ります。
他の場合では、アゴニスト-受容体複合体が分解した後でも、活性化された中間タンパク質はエフェクタータンパク質と相互作用し続けます。その結果、活性化された受容体はごくわずかで、最大の反応を引き起こすのに十分であり、残りは未使用のままになります。
このようなメカニズムにより、細胞はホルモンや神経伝達物質などの低濃度の内因性アゴニストを使用して、完全な応答を生成することができます。
例えば、インスリン受容体の99%は予備です。残りのものは低インスリン濃度で活性化され、24時間血糖値を維持します。
予備の受容体は、大きな受容体プールで薬物と受容体の相互作用の可能性が高まるため、アゴニスト薬に対する細胞の感受性も高めます。
Q1: What are spare receptors and why do cells have them?
Spare receptors are unoccupied receptors that remain unused even when an agonist produces a maximal biological response. Cells maintain spare receptors as functional reserves, allowing them to economically use low concentrations of endogenous agonists such as hormones and neurotransmitters. This mechanism ensures cells can generate full responses without requiring all receptors to be activated, providing efficiency and sensitivity to signaling molecules.
Q2: How do spare receptors amplify cellular signals?
Spare receptors amplify signals through two mechanisms. First, a single agonist-receptor complex can activate multiple downstream effector proteins, so receptor numbers exceed available effector molecules. Second, activated effector molecules continue interacting with target proteins even after the agonist-receptor complex dissociates. These mechanisms allow only a fraction of receptors to produce maximal response, leaving the rest unused and available for signal amplification.
Q3: How is the presence of spare receptors detected experimentally?
Scientists detect spare receptors by comparing EC50 (drug concentration producing 50% maximum effect) with Kd (drug concentration occupying 50% of receptors). If EC50 is smaller than Kd, spare receptors are present. This comparison reveals that maximal effects occur with fewer than 100% of receptors occupied, indicating the existence of functional reserves that support signal amplification and cellular sensitivity.
Q4: Why do cells need higher antagonist concentrations when spare receptors are present?
When spare receptors are present, antagonists must occupy a larger proportion of total receptors to block agonist effects. For example, insulin receptors are 99% spare, so antagonists must occupy nearly all receptors to counteract insulin's response. In contrast, the heart has only 5-10% spare β-adrenoceptors, requiring lower antagonist concentrations. This relationship between spare receptor abundance and antagonist requirement reflects the functional reserve available for signal transduction.
Q5: How do spare insulin receptors maintain blood glucose homeostasis?
Approximately 99% of insulin receptors are spare, meaning only a small fraction of activated receptors are needed to allow glucose uptake and meet cellular energy requirements. This high proportion of spare receptors makes cells extremely sensitive to small changes in insulin concentration, enabling precise regulation of blood glucose levels around the clock. The spare receptors act as a buffer, ensuring consistent metabolic response despite fluctuating hormone levels.
Q6: What is the relationship between receptor occupancy and maximal biological response?
Maximal biological response does not require 100% receptor occupancy due to spare receptors and signal amplification mechanisms. One agonist-receptor complex can activate multiple effector molecules, and activated intermediary proteins continue signaling after the complex dissociates. This allows cells to achieve full response with partial receptor occupancy, demonstrating that biological efficacy depends on signal amplification rather than complete receptor saturation.
Q7: How do spare receptors increase cellular sensitivity to agonist drugs?
Spare receptors increase drug sensitivity by expanding the available receptor pool for drug-receptor interactions. With more unoccupied receptors present, the probability of drug molecules encountering and binding to receptors increases. This larger target pool makes cells more responsive to lower drug concentrations, enhancing the overall sensitivity of the cell to agonist drugs and allowing therapeutic effects at reduced doses.